There were significant early-stage differences in Podxl and Synpo levels and in late-stage expression of Actn4, Cd2ap, Myh9, Npsh2, Vim, and Wt1. Their decreased expression correlated significantly with glomerular dysfunction from early GN (Table S2). Here, PODXL is linked to ganglioneuroma.